#Digital Therapeutics Market segment

[marketinsight1234]

Global Digital Therapeutics market Size Expected To Reach USD 12880 Million With CAGR 20.41% By 2030

The Global Digital Therapeutics market size was reasonably estimated to be approximately USD 6050 Million in 2023 and is poised to generate revenue over USD 12880 Million by the end of 2030, projecting a CAGR of around 20.41% from 2023 to 2030.

The Digital Therapeutics Market is a dynamic and rapidly growing sector within the broader healthcare industry. Digital therapeutics, often referred to as "DTx," encompass a range of software-based interventions that are designed to prevent, manage, or treat various medical conditions. These solutions leverage technology, such as mobile apps, wearable devices, and web-based platforms, to deliver evidence-based therapeutic interventions directly to patients. As the world becomes more digitally connected and the healthcare landscape continues to evolve, the digital therapeutics market is poised for substantial growth.

Leading players involved in the Digital Therapeutics Market include:

"Omada Health Inc. (US), ResMed (US), Pear Therapeutics Inc. (US), Solera Network (US),  Akili Interactive Labs Inc. (US), Better Therapeutics LLC (US), Biofourmis (US), Click Therapeutics Inc. (US), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (US), Happify Inc. (US), Limbix Health Inc. (US), Voluntis (US), Xealth (US), Biobeat (Israel), Kaia Health (US), Ginger (US), Propeller Health (US), Hinge Health Inc. (US) And Other Major Key Players." 

Get Sample Report: -

https://pristineintelligence.com/request-sample/digital-therapeutics-market-22

Updated Version 2023 is available our Sample Report May Includes the:

Scope For 2023

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (structure of the report)

Research methodology adopted by Worldwide Market Reports

The latest research on the Digital Therapeutics market provides a comprehensive overview of the market for the years 2023 to 2030. It gives a comprehensive picture of the global Digital Therapeutics industry, considering all significant industry trends, market dynamics, competitive landscape, and market analysis tools such as Porter's five forces analysis, Industry Value chain analysis, and PESTEL analysis of the Digital Therapeutics market. Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years. The report is designed to help readers find information and make decisions that will help them grow their businesses. The study is written with a specific goal in mind: to give business insights and consultancy to help customers make smart business decisions and achieve long-term success in their particular market areas.

Market Driver:

One of the primary drivers of the digital therapeutics market is the increasing prevalence of chronic diseases and the need for effective, scalable, and cost-efficient treatment options. Conditions such as diabetes, hypertension, obesity, and mental health disorders are on the rise globally. Digital therapeutics offer a solution by providing personalized, data-driven interventions that empower patients to actively manage their conditions. These solutions not only reduce the burden on healthcare systems but also improve patient outcomes through continuous monitoring, feedback, and support.

Market Opportunity:

An exciting opportunity within the digital therapeutics market is the integration of artificial intelligence (AI) and machine learning technologies. AI has the potential to enhance the effectiveness of digital therapeutics by enabling more personalized and adaptive interventions. By analysing vast amounts of patient data, AI algorithms can tailor treatment plans to individual needs, predict disease progression, and even suggest real-time adjustments to improve therapeutic outcomes. This integration opens doors for innovative solutions that can revolutionize healthcare by providing more precise, efficient, and patient-centric treatments.

If You Have Any Query Digital Therapeutics Market Report, Visit:

https://pristineintelligence.com/inquiry/digital-therapeutics-market-22

Segmentation of Digital Therapeutics Market:       

By Type

Device

Software

Hybrid

By Application

Mental Health

Diabetes Management

Cardiovascular Disease

Respiratory Disorders

Obesity Management

Neurological Disorders

Others

By Sales Channel

App Store

B2C

Others

By End Users

Patients

Healthcare Providers

Employers

Insurers/Payers

Others

An in-depth study of the Digital Therapeutics industry for the years 2023–2030 is provided in the latest research. North America, Europe, Asia-Pacific, South America, the Middle East, and Africa are only some of the regions included in the report's segmented and regional analyses. The research also includes key insights including market trends and potential opportunities based on these major insights. All these quantitative data, such as market size and revenue forecasts, and qualitative data, such as customers' values, needs, and buying inclinations, are integral parts of any thorough market analysis.

Market Segment by Regions: -

North America (US, Canada, Mexico)

Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)

Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)

Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)

Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)

South America (Brazil, Argentina, Rest of SA)

Effective Points Covered in Digital Therapeutics Market Report: -

Details Competitor analysis with accurate, up-to-date demand-side dynamics information.

Standard performance against major competitors.

Identify the growth segment of your investment.

Understanding most recent innovative development and supply chain pattern.

Establish regional / national strategy based on statistics.

Develop strategies based on future development possibilities. 

Purchase This Reports: -

https://pristineintelligence.com/buy-now/22

About Us:

We are technocratic market research and consulting company that provides comprehensive and data-driven market insights. We hold the expertise in demand analysis and estimation of multidomain industries with encyclopedic competitive and landscape analysis. Also, our in-depth macro-economic analysis gives a bird's eye view of a market to our esteemed client. Our team at Pristine Intelligence focuses on result-oriented methodologies which are based on historic and present data to produce authentic foretelling about the industry. Pristine Intelligence's extensive studies help our clients to make righteous decisions that make a positive impact on their business. Our customer-oriented business model firmly follows satisfactory service through which our brand name is recognized in the market.

Contact Us:

Office No 101, Saudamini Commercial Complex,

Right Bhusari Colony,

Kothrud, Pune,

Maharashtra, India - 411038 (+1) 773 382 1049 +91 - 81800 - 96367

Email: sales@pristineintelligence.com

[rameshjadhav]

Digital Therapeutics And Wellness Market Size and Share 2022 Industry Analysis by Future and Growth Forecast to 2028

Global Digital Therapeutics and Wellness Market was valued at USD 4.14 Billion in 2021 and is expected to reach USD 15.50 Billion by the year 2028, at a CAGR of 20.41%.

Digital Therapy (DTx) is a category of digital health that the Digital Therapeutics Alliance refers to as products that provide evidence-based therapeutic engagement to patients using high-quality software programs to prevent, manage, or treat a medical condition. or disease. Digital therapies are different from digital medications or "smart pills," which combine a prescription medication with an ingestible sensor that is designed to communicate with a software application to track compliance. The development and increasingly dominant role of mobile technology and artificial intelligence (AI) in our daily lives have expanded the role of digital therapy and wellness in healthcare.

The major factor expected to drive the growth of the Digital Wellness and Therapeutics market during the forecast period includes the increasing penetration of smartphones in both developed and developing countries. Other important factors, such as the profitability of digital health technology for providers and patients, and the increasing demand for integrated health systems and patient-centric care, are expected to drive market growth during the analysis period.

Read More:

[semiconductor-hub]

Microwave Devices Market Revenue, Demand, Segment and Forecast by 2032

Microwave devices are crucial components in various telecommunications, radar, and electronic warfare applications. Operating in the microwave frequency range, typically defined as 1 GHz to 300 GHz, these devices encompass a wide array of technologies, including amplifiers, oscillators, filters, and antennas. Microwave devices are essential for enabling high-speed communication and precise targeting in radar systems, making them integral to modern electronic systems.

The advancement of microwave technology has facilitated significant improvements in performance and functionality. With the growing demand for high-frequency communication, the development of microwave devices has accelerated, driven by innovations in materials, design techniques, and manufacturing processes. These advancements have resulted in devices that exhibit high efficiency, low power consumption, and improved reliability, addressing the requirements of both commercial and military applications.

The Microwave Devices Market Size was valued at USD 7.1 billion in 2023 and is expected to reach USD 11.2 billion by 2031 and grow at a CAGR of 5.8 % over the forecast period 2024-2031.

Future Scope

The future of microwave devices is promising, with strong growth anticipated across several sectors. The proliferation of 5G technology is a major driving force, as it necessitates the deployment of microwave devices to support high-speed data transmission and low-latency communication. As telecommunications providers upgrade their infrastructure to accommodate 5G, the demand for advanced microwave components will continue to rise.

Additionally, the increasing use of microwave devices in satellite communications and space exploration will further fuel market growth. The need for reliable and high-performance microwave systems in these applications is critical for ensuring effective communication and data transmission in challenging environments.

Another significant factor shaping the future of microwave devices is the rise of the Internet of Things (IoT). As IoT applications proliferate, the demand for efficient and compact microwave devices that can support diverse connectivity requirements will grow. Innovations in miniaturization and integration will play a key role in meeting these demands.

Trends

Several key trends are influencing the microwave devices market. One prominent trend is the shift towards solid-state technology in microwave amplifiers and oscillators. Solid-state devices offer enhanced reliability and performance compared to traditional vacuum tube technologies, making them suitable for a wider range of applications.

Another trend is the increasing integration of microwave devices with digital signal processing (DSP) technologies. This integration allows for more sophisticated signal manipulation and processing, enabling enhanced performance in applications such as radar and telecommunications. The combination of microwave and DSP technologies is paving the way for more advanced and capable systems.

Application

Microwave devices are widely used across various industries, including telecommunications, aerospace, defense, and medical applications. In telecommunications, microwave devices facilitate high-speed data transmission in mobile networks and satellite communications. Their ability to operate at high frequencies allows for efficient communication over long distances.

In aerospace and defense, microwave devices are integral to radar systems and electronic warfare applications. These devices provide the precision and reliability required for tracking and targeting, ensuring operational effectiveness in challenging environments.

Additionally, microwave technology is gaining traction in medical applications, particularly in diagnostic imaging and therapeutic treatments. Microwave devices are being explored for their potential in minimally invasive surgeries and cancer treatment, where precise control and targeting are essential.

Key Points

Crucial components in telecommunications, radar, and electronic warfare applications.

Significant advancements in performance and reliability driven by innovations in materials and design.

Future growth fueled by 5G technology, satellite communications, and IoT applications.

Trends include the shift towards solid-state technologies and integration with DSP.

Applied across telecommunications, aerospace, defense, and medical sectors.

Read More Details: https://www.snsinsider.com/reports/microwave-devices-market-1884 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[tamanna31]

Clinical Trials 2024 Industry Size, Demands, Growth and Top Key Players Analysis Report

Clinical Trials Industry Overview

The global clinical trials market size was valued at USD 80.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. 

The market growth spiked in 2020 owing to the COVID-19 pandemic. This growth pattern was witnessed by both virtual clinical trials and traditional ones. Several companies invested heavily in novel drug development to minimize COVID-19 patient burden. One such example being, in 2020, Synairgen plc and Parexel collaborated on a Phase III study of Interferon-beta (IFN-beta) treatment for COVID-19. Furthermore, rapid technological evolution, rising prevalence of chronic diseases, globalization of clinical trials, penetration of personalized medicine and a rise in demand for CROs for conducting research activities is expected to positively impact the market growth.

Gather more insights about the market drivers, restrains and growth of theClinical Trials Market

In addition, the COVID-19 pandemic led to changing the ways of conducting upcoming or ongoing clinical trials. Regulatory agencies including the U.S. FDA, the European Medicines Agency (EMA), the National Institutes of Health (NIH), and China’s National Medical Products Administration among several others issued various guidelines for conducting trials during the pandemic to support the implementation of decentralized clinical trials and virtual services. The current scenario for research and development activities across the globe and the need for several new treatment options have also led to the adoption of fast-track clinical trials. Thus, aforementioned factors are estimated to offer new avenues to the clinical trials market growth.

Favorable government support and initiatives is another aspect boosting the market growth potential. For instance, the WHO launched Solidarity, an international clinical trial to determine effective treatment against COVID-19. [PS2]  It includes comparing four treatment options against the standard of care to evaluate their effectiveness against the coronavirus. In May 2020, the WHO also announced an international alliance for simultaneously developing multiple candidate vaccines to prevent the spread of the coronavirus disease, calling this effort the Solidarity trial for vaccines.

Furthermore, the use of CRO services helps manufacturers/sponsors pay complete attention to the production capacity and enhance their in-house processes. The availability of the vast array of services from drug discovery to post marketing surveillance has further simplified processes for mid-size & small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource research and development activities to reduce infrastructure investment. For instance, in November 2023, Syneos Health signed an agreement with GoBroad Healthcare Group. This collaborative initiative extended the company’s clinical trial capabilities into a more extensive array of therapeutic areas in China.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

The global digital neuro biomarkers market size was estimated at USD 593.1 million in 2023 and is projected to grow at a CAGR of 25.3% from 2024 to 2030.

The global healthcare digital experience platform market size was valued at USD 1.26 billion in 2023 and is forecasted to grow at a CAGR of 12.5% from 2024 to 2030.

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, sponsor, indication by study design, and region:

Clinical Trials Phase Outlook (Revenue, USD Billion, 2018 - 2030)

Phase I

Phase II

Phase III

Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

Interventional

Observational

Expanded Access

Clinical Trials Indication by Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

Autoimmune/Inflammation

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome (IBS)

Others

Pain Management

Chronic Pain

Acute Pain

Oncology

Blood Cancer

Solid Tumors

Other

CNS Condition

Epilepsy

Parkinson's Disease (PD)

Huntington's Disease

Stroke

Traumatic Brain Injury (TBI)

Amyotrophic Lateral Sclerosis (ALS)

Muscle Regeneration

Others

Diabetes

Obesity

Cardiovascular

Others

Clinical Trials Indication Outlook (Revenue, USD Billion, 2018 - 2030)

Autoimmune/Inflammation

Interventional

Observational

Expanded Access

Pain Management

Interventional

Observational

Expanded Access

Oncology

Interventional

Observational

Expanded Access

CNS Condition

Interventional

Observational

Expanded Access

Diabetes

Interventional

Observational

Expanded Access

Obesity

Interventional

Observational

Expanded Access

Cardiovascular

Interventional

Observational

Expanded Access

Others

Interventional

Observational

Expanded Access

Clinical Trials Sponsor Outlook (Revenue, USD Billion, 2018 - 2030)

Pharmaceutical & Biopharmaceutical Companies

Medical Device Companies

Others

Clinical Trials Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

Protocol Designing

Site Identification

Patient Recruitment

Laboratory Services

Bioanalytical Testing Services

Clinical Trial Data Management Services

Others

Clinical Trials Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Spain

Italy

Asia Pacific

India

Japan

China

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Key Companies profiled:

IQVIA

PAREXEL International Corporation

Pharmaceutical Product Development, LLC

Charles River Laboratory

ICON Plc

PRA Health Sciences

Syneos Health

Eli Lilly and Company

Novo Nordisk A/S

Pfizer

Clinipace

Recent Developments

In August 2023, Parexel & Partex entered a strategic partnership aimed at utilizing Artificial Intelligence (AI)-driven solutions to expedite the process of drug discovery and development for biopharmaceutical clients globally. The collaboration aimed to reduce risks associated with the assets in their respective portfolios.

In August 2023, Novo Nordisk announced to acquire Inversago Pharma. This acquisition was part of Novo Nordisk's strategic efforts to develop new therapies targeting individuals with obesity, diabetes, and other significant metabolic diseases

Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research.

[marketresearchintent]

Augmented and Virtual Reality Market: Bridging the Gap Between Real and Virtual Worlds

In an era where digital experiences are becoming increasingly intertwined with our physical reality, the Augmented Reality (AR) and Virtual Reality (VR) market stands at the forefront of technological innovation. This burgeoning sector is not just reshaping how we interact with digital content but is poised to revolutionize industries ranging from healthcare and education to entertainment and retail. According to recent market projections, the Augmented and Virtual Reality Market is expected to grow from USD 23.8 billion in 2023 at a compound annual growth rate (CAGR) of 22.6% to reach an impressive USD 99.4 billion by 2030. This remarkable growth trajectory underscores the transformative potential of AR and VR technologies and their increasing adoption across various sectors.

Understanding AR and VR: The Technologies Shaping Our Future

Before delving into the market dynamics, it's crucial to understand what AR and VR entail. Augmented Reality overlays digital information onto the real world, enhancing our perception and interaction with our surroundings. On the other hand, Virtual Reality immerses users in a completely digital environment, offering experiences that can range from the realistic to the fantastical. While distinct, both technologies share the common goal of blending digital elements with our perception of reality, albeit to different degrees.

Access Full Report @ https://intentmarketresearch.com/latest-reports/augmented-and-virtual-reality-market-3099.html  

Key Drivers of Market Growth

The projected growth from USD 23.8 billion to USD 99.4 billion in just seven years is propelled by several key factors:

Technological Advancements: Continuous improvements in hardware capabilities, including more powerful processors, higher-resolution displays, and more accurate motion tracking, are making AR and VR experiences more immersive and accessible.

Expanding Application Areas: While gaming and entertainment were early adopters, sectors such as healthcare, education, retail, and manufacturing are increasingly leveraging AR and VR for training, visualization, and operational efficiency.

Growing Enterprise Adoption: Businesses are recognizing the potential of AR and VR for improving productivity, enhancing customer experiences, and creating new revenue streams.

Increasing Consumer Awareness: As AR and VR technologies become more mainstream, consumer familiarity and acceptance are growing, driving demand for both hardware and content.

Investment in Infrastructure: The rollout of 5G networks is enhancing the capabilities of AR and VR applications, enabling more responsive and data-rich experiences.

Market Segments and Growth Areas

The AR and VR market can be segmented based on technology, component, device type, and application. Each segment presents unique growth opportunities:

Technology:

Augmented Reality: Expected to see robust growth due to its versatility and lower barrier to entry compared to VR. Applications range from smartphone-based AR to advanced headsets for industrial use.

Virtual Reality: While requiring more specialized hardware, VR is seeing strong growth in gaming, training simulations, and therapeutic applications.

Components:

Hardware: Including headsets, displays, cameras, and sensors. This segment is witnessing rapid innovation, with a focus on improving comfort, resolution, and field of view.

Software: The development of more sophisticated AR/VR applications and platforms is crucial for market growth, with a focus on user-friendly content creation tools.

Device Type:

Head-Mounted Displays (HMDs): These remain the primary device for immersive VR experiences and are seeing improvements in both performance and affordability.

Smart Glasses: AR-enabled smart glasses are gaining traction in enterprise settings for hands-free information access and task guidance.

Handheld Devices: Smartphones and tablets continue to be important platforms for AR applications, benefiting from their ubiquity and improving capabilities.

Applications:

Gaming and Entertainment: Historically the largest market for VR, this sector continues to drive consumer adoption and content innovation.

Healthcare: AR and VR are revolutionizing medical training, surgical planning, and patient therapy.

Education and Training: Immersive learning experiences are enhancing education at all levels, from K-12 to professional development.

Retail and E-commerce: AR is transforming the shopping experience, allowing customers to visualize products in their own spaces before purchase.

Manufacturing and Design: VR is streamlining product design and prototyping processes, while AR is enhancing assembly and maintenance procedures.

Download Sample Report @ https://intentmarketresearch.com/request-sample/augmented-and-virtual-reality-market-3099.html 

Challenges and Opportunities

Despite the optimistic growth projections, the AR and VR market faces several challenges:

Hardware Limitations: Current devices still face issues with weight, battery life, and visual fidelity, which can impact user comfort and adoption.

Content Creation: The need for high-quality, engaging content remains crucial. Developing compelling AR and VR experiences requires specialized skills and can be resource-intensive.

Privacy and Security Concerns: As AR and VR technologies collect more personal and environmental data, addressing privacy and security issues becomes paramount.

Standardization: The lack of industry-wide standards can hinder interoperability and slow down adoption in enterprise settings.

However, these challenges also present opportunities for innovation and market differentiation. Companies that can address these issues effectively are likely to gain significant market share.

The Road Ahead: Emerging Trends and Future Outlook

As the AR and VR market continues its rapid expansion, several trends are shaping its future:

Mixed Reality (MR): The blending of AR and VR technologies is creating more flexible and powerful applications, potentially expanding use cases and market reach.

AI Integration: The incorporation of artificial intelligence is enhancing the capabilities of AR and VR systems, enabling more natural interactions and personalized experiences.

Haptic Feedback: Advancements in haptic technology are set to increase the immersion and realism of VR experiences, opening new possibilities in training and simulation.

Enterprise Solutions: The growing adoption of AR and VR in enterprise settings for training, remote collaboration, and data visualization is expected to be a major driver of market growth.

Metaverse Development: The concept of the metaverse, a persistent shared virtual space, is driving investment and innovation in AR and VR technologies.

Conclusion

The projected growth of the Augmented and Virtual Reality Market from USD 23.8 billion in 2023 to USD 99.4 billion by 2030 represents more than just impressive numbers. It signifies a fundamental shift in how we interact with digital information and with each other. As these technologies continue to evolve and integrate into our daily lives and work environments, they promise to unlock new realms of creativity, productivity, and human experience.

About Us

Intent Market Research (IMR) is dedicated to delivering distinctive market insights, focusing on the sustainable and inclusive growth of our clients. We provide in-depth market research reports and consulting services, empowering businesses to make informed, data-driven decisions.

Our market intelligence reports are grounded in factual and relevant insights across various industries, including chemicals & materials, healthcare, food & beverage, automotive & transportation, energy & power, packaging, industrial equipment, building & construction, aerospace & defense, and semiconductor & electronics, among others.

We adopt a highly collaborative approach, partnering closely with clients to drive transformative changes that benefit all stakeholders. With a strong commitment to innovation, we aim to help businesses expand, build sustainable advantages, and create meaningful, positive impacts.

Contact Us

sales@intentmarketresearch.com

US: +1 463-583-2713

[health-views-updates]

The Future of the Insomnia Therapeutics Market: What to Expect

The global insomnia therapeutics market, valued at USD 2.50 billion in 2023, is projected to reach USD 3.71 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.53% during the forecast period from 2024 to 2032. Increasing cases of insomnia, heightened awareness about sleep disorders, and ongoing developments in therapeutic treatments are key drivers of market growth.

As sleep disorders continue to affect millions worldwide, the demand for effective insomnia treatments is rising steadily. Insomnia, characterized by difficulties in falling or staying asleep, has become a widespread health issue, with consequences that range from reduced productivity to serious mental and physical health complications. The need for more targeted, efficient therapeutics is essential as the healthcare industry seeks to address this growing issue.

Key Market Drivers

Increasing Prevalence of Sleep Disorders Sleep disorders, particularly insomnia, have seen a significant rise in recent years. According to studies, nearly 10-30% of the adult population suffers from chronic insomnia, with even higher numbers reporting occasional episodes. Factors such as increased stress, digital screen exposure, and shifting work patterns, including night shifts and irregular hours, have contributed to the surge in insomnia cases. As awareness of these sleep disorders increases, so too does the demand for advanced therapeutic options to manage them effectively.

Advancements in Therapeutics The insomnia therapeutics market is being bolstered by innovations in treatment options, including non-benzodiazepine sleep aids, melatonin receptor agonists, and cognitive behavioral therapy (CBT) applications. While traditional medications, such as benzodiazepines and sedative-hypnotics, have been widely prescribed, the emergence of newer, safer alternatives has expanded the treatment landscape. Research into more precise therapeutic approaches, including personalized medicine, is providing a new avenue for addressing the specific needs of patients suffering from chronic insomnia.

Increasing Focus on Mental Health and Well-being Growing awareness of mental health issues has also pushed sleep disorders to the forefront of healthcare conversations. Lack of sleep can exacerbate or even contribute to the development of anxiety, depression, and other mental health disorders. Consequently, healthcare providers and policymakers are recognizing the importance of treating sleep disorders as part of a comprehensive mental health strategy. This focus on holistic health is expected to further boost the insomnia therapeutics market.

Rise in Geriatric Population The global aging population is another key factor driving market growth. As people age, they are more prone to sleep disturbances, including insomnia. According to the World Health Organization, the global population aged 60 years and older is expected to reach 2.1 billion by 2050. This demographic shift is expected to increase the demand for insomnia therapeutics as older adults frequently experience difficulties with sleep due to underlying health conditions, medications, or age-related changes in sleep patterns.

Growing Use of Over-the-Counter (OTC) Sleep Aids OTC sleep aids, such as antihistamines and melatonin supplements, have become increasingly popular among individuals seeking immediate relief from insomnia. Although prescription medications dominate the market, the convenience and availability of OTC products are expected to contribute to market growth, particularly among individuals who experience mild or occasional sleep disturbances.

Get Free Sample Report: https://www.snsinsider.com/sample-request/4524 

Market Segmentation

The insomnia therapeutics market is segmented based on therapy type, distribution channel, and region.

By Therapy Type:

Pharmacological Treatments Pharmacological treatments, including benzodiazepines, non-benzodiazepines, melatonin receptor agonists, and orexin receptor antagonists, continue to dominate the insomnia therapeutics market. The non-benzodiazepine class of medications is gaining popularity due to its lower risk of dependence and side effects compared to traditional benzodiazepines.

Cognitive Behavioral Therapy for Insomnia (CBT-I) CBT-I is recognized as the gold-standard treatment for insomnia, particularly chronic insomnia. This non-pharmacological approach helps individuals develop healthy sleep habits and addresses the underlying psychological factors contributing to sleep disturbances. Increasing awareness of CBT-I as an effective, drug-free treatment option is expected to drive demand for therapeutic solutions based on this method.

OTC Medications and Supplements Over-the-counter sleep aids, including antihistamines and melatonin, are commonly used for short-term relief of insomnia symptoms. While they are often preferred for their accessibility and low cost, healthcare professionals typically recommend caution due to potential side effects and limited long-term efficacy.

By Distribution Channel:

Retail Pharmacies Retail pharmacies remain a primary distribution channel for both prescription and OTC insomnia therapeutics, providing easy access to medications for individuals seeking treatment for sleep disorders.

Online Pharmacies The rise of e-commerce has made online pharmacies a rapidly growing channel for insomnia therapeutics. Patients can conveniently order prescription medications and OTC sleep aids from online platforms, boosting market growth, particularly among tech-savvy consumers.

Hospital Pharmacies Hospital pharmacies play a crucial role in the distribution of prescription-based insomnia treatments, particularly for patients with severe or chronic insomnia who require more specialized care.

Regional Insights

North America North America holds the largest share of the insomnia therapeutics market due to high awareness of sleep disorders, advanced healthcare infrastructure, and significant use of both prescription and OTC sleep aids. The U.S. market, in particular, is driven by rising cases of insomnia due to stress, anxiety, and lifestyle factors, as well as the ongoing focus on mental health.

Europe Europe is the second-largest market for insomnia therapeutics, with countries like Germany, the U.K., and France leading in terms of demand. The region's growing aging population and increasing recognition of the link between mental health and sleep disorders contribute to market growth.

Asia-Pacific The Asia-Pacific region is expected to see substantial growth during the forecast period, driven by an increase in healthcare awareness, rising disposable incomes, and the growing prevalence of insomnia, particularly in countries like China, India, and Japan. Rapid urbanization and the adoption of Westernized work patterns and lifestyles have led to increased stress and sleep-related issues, fueling demand for insomnia therapeutics.

Key Market Players

Leading players in the insomnia therapeutics market include:

Merck & Co. Known for its product Belsomra, Merck is a major player in the insomnia therapeutics market. Its innovative approach to sleep disorders, particularly with orexin receptor antagonists, has gained widespread recognition.

Eisai Co., Ltd. Eisai’s Dayvigo, another orexin receptor antagonist, has made significant strides in the market, offering a new option for individuals with chronic insomnia.

Sanofi Sanofi remains a leader in OTC sleep aids with its popular melatonin-based products. The company continues to expand its reach with new formulations and innovations in the sleep therapeutics space.

Pfizer Inc. As a major pharmaceutical company, Pfizer offers a variety of insomnia medications and continues to focus on research and development for new therapeutic options.

Future Outlook

As the global population continues to face increasing stress levels and sleep-related issues, the demand for insomnia therapeutics will grow steadily. The market's expansion will be driven by ongoing advancements in treatment options, a rising geriatric population, and increased awareness of the health risks associated with sleep disorders.

[namocreations]

How To Start Candle Making Business in India

Starting a candle making business in India can be a rewarding venture, combining creativity with entrepreneurship. The growing demand for candles, driven by their usage in decor, aromatherapy, and gifting, makes this a promising market. Here’s a comprehensive guide to help you kickstart your candle-making business in India.

1. Understanding the Candle Market in India The Indian candle market is thriving, with a steady increase in demand for both decorative and aromatic candles. Consumers are increasingly opting for eco-friendly, handmade, and designer candles, creating opportunities for small-scale businesses. Research current market trends, target customer segments, and potential competitors to carve out your niche.

2. Developing a Business Plan A well-thought-out business plan is the foundation of your venture. Outline your business goals, target audience, budget, and marketing strategies. Consider the types of candles you want to produce — whether decorative, scented, or therapeutic — and identify your unique selling proposition (USP) that will differentiate your brand in the market.

3. Legal Formalities and Registration Before you begin production, ensure your business is legally compliant. Register your business under the appropriate legal structure, such as a sole proprietorship, partnership, or private limited company. Obtain necessary licenses, such as a trade license from the local municipal authority and GST registration if your turnover exceeds the specified limit.

4. Setting Up Your Workspace You don’t need a large space to start a candle-making business; a small room or a dedicated workspace at home can suffice. Ensure your workspace is well-ventilated and has ample storage for raw materials like wax, wicks, molds, and fragrances. Invest in basic equipment like a double boiler, thermometer, weighing scale, and safety gear.

5. Sourcing Raw Materials Quality raw materials are crucial for producing premium candles. Identify reliable suppliers for wax (paraffin, soy, or beeswax), wicks, molds, dyes, fragrances, and essential oils. Consider sourcing eco-friendly materials to cater to the growing demand for sustainable products. Buying in bulk can also help reduce costs.

6. Mastering the Art of Candle Making Candle making is both an art and a science. Experiment with different waxes, fragrances, and molds to create unique designs. Focus on achieving the right balance of fragrance and burn time. You can start with simple designs and gradually move to more complex patterns and techniques like layering, embedding, or carving.

7. Branding and Packaging Your brand identity plays a crucial role in attracting customers. Develop a brand name, logo, and packaging that reflects the essence of your candles. Invest in attractive and eco-friendly packaging that not only protects your products but also appeals to your target audience. Personalized labels and tags can add a unique touch.

8. Pricing Your Products Pricing is a critical factor in your business’s success. Consider the cost of raw materials, labor, packaging, and other overheads while determining your pricing strategy. Research your competitors’ prices and aim for a balance between affordability and profitability. Offering a range of price points can cater to different customer segments.

9. Marketing and Sales Strategies In today’s digital age, online presence is key to reaching a wider audience. Create a professional website and leverage social media platforms like Instagram and Facebook to showcase your products. Collaborate with influencers, participate in local markets, and offer promotions to boost visibility. You can also explore listing your products on e-commerce platforms like Amazon and Etsy.

10. Scaling Your Business Once you’ve established a steady customer base, consider expanding your product range or venturing into related segments like candle accessories or gift sets. You can also explore B2B opportunities by supplying to hotels, spas, and event planners. Continuous innovation and customer feedback will help you grow and sustain your business in the long run.

Conclusion Starting a candle-making business in India is an exciting opportunity to blend creativity with entrepreneurship. With the right planning, quality products, and effective marketing, you can carve a niche for yourself in this growing market. Remember, patience and persistence are key as you embark on this entrepreneurial journey.

Namo Creations has been dedicated to providing top-tier candle-making Raw Material. We prioritize excellence, using the finest materials for an unparalleled experience. This dedication extends to assisting newcomers and small business owners in candle making. We believe in empowering creativity with quality materials. Namo Creations offers guidance and training, nurturing budding artisans. Join us in this passionate journey of quality, creativity, and community, lighting the way to a fragrant future.

[communicationblogs]

Digital PCR Market — Forecast(2024–2030)

Digital PCR Market Overview

Request Sample

Report Coverage

The report: “Digital PCR Market Forecast (2024–2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Digital PCR Market.

By Product: Consumables & Reagents and Software & Services

By Technology Type: Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR

By Indication: Infectious Disease, Oncology, Genetic Disorders, and Others

By Application: Research, Clinical Diagnostics, Forensics, and Others

By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa).

Inquiry Before Buying

Key Takeaways

North America dominated the Digital PCR Market in 2020 owing to the increasing demand for rapid diagnostic tests and high diagnosis rates for infectious disease. The Digital PCR Market scope for different regions will be provided in the final report.

Technological advancements in digital PCR and growing adoption of digital PCR over real time PCR are likely to aid the market growth of the Digital PCR Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Digital PCR Market report.

High cost of digital PCR devices and reimbursement issues along with the technical limitations of PCR is poised to create hurdles for the Digital PCR Market.

Digital PCR Market Segment Analysis — By Technology Type

Droplet Digital PCR held the largest share in the Digital PCR Market in 2020 and is estimated to grow at a CAGR of 9.7% during the forecast period 2024–2030. This is attributed to the technological advances along with various new product launches. Droplet digital PCR is based on water oil emulsion droplet technology and for the amplification of the template molecules in each individual droplet. It also uses workflows and reagents for most standard probe based assays. Droplet digital PCR also measure the copy number variation by partitioning a PCR reaction into nanoliter droplets. The cross-contamination drawback of droplet digital PCR is increasing the demand of chip based digital PCR. Droplet digital PCR are estimated to register the highest CAGR over the period 2024–2030.

Schedule a Call

Digital PCR Market Segment Analysis — By Indication

Infectious disease held the largest share in the Digital PCR Market in 2020 and is estimated to grow at a CAGR 8.6% during the forecast period 2021–2026. This is attributed to the advantages of the droplet digital PCR of infectious diseases such as bacterial, viral, and parasitic indications. Digital PCR provides more accurate, sensitive, and reproductive detection of pathogens according to the National Center for Biotechnology and it is better than real time polymerase chain reaction that are used for clinical diagnostics. The demand of oncology is increasing owing to the growing prevalence of the condition and introduction of new product launches. Oncology are estimated to register the highest CAGR over the period 2024–2030.

Digital PCR Market Segment Analysis — By Geography

North America dominated the Digital PCR Market with a major share of 37.6% in 2020. This is attributed to the high prevalence & diagnosis rates for infectious disease and high awareness among patient population towards new diagnostic options. Availability of digital PCR devices, rising incidences of various types of cancer and metabolic diseases requiring advanced diagnosis and therapeutics is also increasing the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2024–2030 owing to the growing patient awareness regarding advanced digital polymerase chain reaction devices. Developing Healthcare infrastructure is also increasing the growth of the market in this region.

Buy Now

Digital PCR Market Drivers

Technological Advancements in Digital PCR

Technological advancements in digital PCR is increasing the growth of the Digital PCR Market. This is attributed to the growing demand for innovative devices and increasing research & development activities. Digital PCR is used to quantify and amplify nuclei acid. The introduction of various technologically advanced devices such as droplet digital PCR, chip based, and beam digital PCR is offering great benefits to the market. Thus, increasing the growth of the Digital PCR Market during the forecast period 2024–2030.

Growing Adoption of Digital PCR over Realtime PCR

Growing adoption of digital PCR over Realtime PCR is increasing the growth of the Digital PCR Market. This is attributed to the fact that digital PCR helps to deliver a compete measure to target nucleic acid molecules that is achieved from real time PCR. DNA quantification allows for reproducibility, precision, and sensitive that enables the researches to quantify smaller differences and measure minor variants very precisely. Thus, increasing the growth of the Digital PCR Market during the forecast period 2024–2030.

Digital PCR Market Challenges

High Cost of Digital PCR Devices and Reimbursement Issues Along with the Technical Limitations of PCR

Some of the factors that are set to impede the growth of the Digital PCR Market are high cost of digital PCR devices and reimbursement issues along with the technical limitations of PCR. The adoption of digital polymerase chain reaction techniques is limited owing to the lack of awareness about the digital PCR and the use of its advanced types.

Digital PCR Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Digital PCR Market. In 2020, the Digital PCR Market share is consolidated by the top ten players present in the market. Digital PCR Market, top 10 companies are Thermo Fisher Scientific Inc., BioMerieux SA, Stilla Technologies, Merck KgaA, Combinati Inc., and Bio-Rad Laboratories among others.

For more Lifesciences and Healthcare Market reports, please click here

[omcmedicalblogs]

Why South Korea is a Booming Market for Medical Devices? - OMC Medical Limited

South Korea has emerged as a significant player in the global medical device market, and its growth trajectory is impressive. The convergence of government support, advanced technology, a strong domestic market, and strategic trade positions South Korea as a hub for medical device innovation and investment. 

Here’s an in-depth exploration of the factors contributing to this booming market. 

1.Government Support and Strategic Policies 

1.1. Regulatory Framework and Incentives 

The South Korean government plays a crucial role in fostering the medical device industry. The Ministry of Food and Drug Safety (MFDS) has streamlined regulatory processes, reducing the time and cost associated with bringing new medical devices to market.

The “Innovative Medical Device Industry Promotion Act,” introduced in 2019, exemplifies the government’s commitment. This legislation provides financial incentives, tax benefits, and support for startups and established companies engaged in R&D.

Additionally, the government has set up the Medical Device Industry Promotion Institute to further drive innovation and international competitiveness. 

1.2. Funding and Grants 

Substantial government funding is available for research and development in the medical device sector. Programs such as the Korea Health Industry Development Institute (KHIDI) offer grants and support for innovative projects, enabling companies to advance their technologies and bring cutting-edge products to market.

The government also encourages public-private partnerships, fostering collaboration between academia, research institutions, and industry players. 

2. Advanced Technology and R&D Capabilities 

2.1. Technological Expertise 

South Korea is globally recognized for its technological advancements, particularly in electronics and IT, which are critical components of modern medical devices. Companies like Samsung and LG, with their expertise in digital technology and imaging, have made significant inroads into the medical device industry.

Innovations in areas such as diagnostic imaging, ultrasound systems, and digital health solutions are driving growth and setting new industry standards.

2.2. Collaborative Ecosystem 

The country’s robust R&D ecosystem is characterized by strong collaboration between universities, research institutions, and private companies. iblbet like Seoul National University Hospital and the Korea Advanced Institute of Science and Technology (KAIST) are at the forefront of medical research, often partnering with industry players to develop innovative solutions.

These collaborations enhance the capacity for breakthrough technologies and ensure a steady pipeline of new products. 

3. Strong Domestic Market 

3.1. Aging Population and Healthcare Demand 

South Korea’s aging population is a significant driver of demand for medical devices. With a growing elderly demographic, the prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is increasing.

This demographic shift necessitates advanced diagnostic, therapeutic, and monitoring devices. The government’s focus on improving healthcare infrastructure and expanding access to medical services further stimulates the market. 

3.2. Healthcare System and Insurance 

South Korea boasts a highly developed healthcare system with universal coverage through the National Health Insurance Service (NHIS). This comprehensive insurance scheme ensures that a broad segment of the population has access to medical services, thereby increasing the demand for medical devices.

The NHIS also facilitates the adoption of new technologies by reimbursing the cost of advanced medical procedures and devices. 

4. Export Opportunities 

4.1. Global Reputation and Quality 

South Korean medical devices are renowned for their quality, reliability, and technological sophistication. This reputation has opened up substantial export opportunities, with South Korean products being highly sought after in markets such as the United States, Europe, and other parts of Asia. 

4.2. Trade Agreements 

South Korea’s strategic trade agreements enhance its position in the global market. The country has established free trade agreements (FTAs) with major economies, including the United States, the European Union, and ASEAN countries.

These agreements reduce tariffs and simplify regulatory requirements, making South Korean medical devices more competitive and accessible in international markets. 

5. Strategic Location and Logistics 

5.1. Geographical Advantage 

South Korea’s strategic location in East Asia makes it a prime hub for trade and distribution. Its proximity to major markets such as China and Japan provides logistical advantages for exporting medical devices.

The country’s well-developed transportation infrastructure, including ports, airports, and a sophisticated logistics network, ensures efficient and timely delivery of products. 

6. Robust Infrastructure and Skilled Workforce 

6.1. Manufacturing Excellence 

South Korea’s advanced manufacturing infrastructure is a cornerstone of its medical device industry. State-of-the-art facilities equipped bola gacor the latest technologies enable high-quality production.

The government’s focus on smart manufacturing and Industry 4.0 principles ensures that South Korean manufacturers remain at the cutting edge of efficiency and quality control. 

6.2. Talent and Education 

The country’s emphasis on education, particularly in science, technology, engineering, and mathematics (STEM), produces a highly skilled workforce. South Korean engineers, scientists, and medical professionals are among the best in the world, driving innovation and maintaining high standards in the medical device industry.

Continuous professional development and a strong culture of research further bolster the industry’s capabilities. 

Conclusion 

South Korea’s medical device market is thriving, driven by a combination of government support, technological innovation, a strong domestic market, and strategic trade advantages. As the country continues to invest in research and development and fosters a conducive environment for business, it is poised to remain a key player in the global medical device industry.

For investors and companies looking to enter this dynamic market, South Korea offers a wealth of opportunities and a promising future. 

By embracing innovation and leveraging its strengths, South Korea is not just keeping pace with global trends but is often setting them, making it an exciting market to watch in the coming years. 

Originally Published at: https://omcmedical.com/south-korea-booming-market-medical-devices/

[cosmenova]

How to Start a Pharma Company with a Low Budget in India?

Starting a pharmaceutical company in India can seem like an ambitious goal, but with careful planning and a strategic approach, it is achievable even with a low budget. The Indian pharma industry is booming, and the increasing demand for healthcare products presents a lucrative opportunity for aspiring entrepreneurs. Companies like Cosmenova, a leading Derma PCD Franchise Company, offer platforms and partnerships that make it easier for individuals to establish their presence in this thriving market. By leveraging existing infrastructure, quality product lines, and the expertise of established brands, newcomers can avoid many financial pitfalls associated with starting from scratch.

With the right strategy, a strong partnership with a franchise provider, and a clear understanding of the market, aspiring business owners can launch their own pharma venture. Below, we’ll explore the steps and important considerations needed to start a pharma company on a limited budget, focusing on cost-saving strategies and leveraging the PCD (Propaganda Cum Distribution) model for growth.

Steps to Start a Low-Budget Pharma Company

Market Research and Niche Selection Before stepping into the pharma industry, it is crucial to identify a specific niche or therapeutic segment. Conduct detailed market research to understand the demand for certain products, gaps in the market, and competition. Choosing a niche like dermatology, which is the specialty of Cosmenova, can help you focus on a growing sector with less competition compared to general medicine.

Leverage the PCD Franchise Model One of the most budget-friendly ways to enter the pharma industry is through the PCD franchise model. By partnering with a reputed company like Cosmenova, you can reduce the financial burden of product development, manufacturing, and brand building. The franchisor provides ready-made products, promotional materials, and marketing support, allowing you to concentrate on sales and distribution.

Obtain Necessary Licenses and Registrations You will need to register your business and obtain essential licenses like the Drug License, GST registration, and company incorporation. Ensure that you comply with all regulatory requirements, which may vary depending on the region. Partnering with a franchise company can often streamline the process since many of these legalities are already in place.

Focus on Lean Marketing Strategies To grow your business on a low budget, consider using digital marketing, social media, and local networks for promotion. Pharma marketing tools like visual aids and doctor interaction can help increase brand visibility without significant expenditure. Cosmenova’s franchise model comes with built-in marketing support, which can reduce the overall cost of advertising.

Cost-Effective Distribution Network Building a strong distribution network is essential to success. By working with a PCD franchise, you can tap into the franchisor’s existing network, helping you reduce logistics and operational costs.

Conclusion

Starting a pharma company on a limited budget may seem challenging, but by aligning with the right partners and utilizing cost-saving models like the PCD franchise system, it becomes manageable. Companies like Cosmenova help entrepreneurs focus on growing their business without the heavy financial burden of production and marketing. With careful planning, market insight, and the right support, you can successfully launch a pharmaceutical company in India while maintaining cost-efficiency.

[amrutatbrc1]

Rheumatology Therapeutics Market 2024 : Size, Growth Rate, Business Module, Product Scope, Regional Analysis And Expansions 2033

The Rheumatology Therapeutics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Rheumatology Therapeutics Market: https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

According to The Business Research Company’s Rheumatology Therapeutics Global Market Report 2024, The rheumatology therapeutics market size is expected to see steady growth in the next few years. It will grow to $51.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to the shift towards personalized medicine approaches, rising adoption of biosimilars in rheumatology, increasing investment in research and development, integration of digital health technologies, and regulatory approvals for novel therapies. Major trends in the forecast period include growth in telemedicine and remote monitoring solutions, expansion of targeted therapies for specific rheumatic conditions, emphasis on patient-centric care models, expansion of biologic treatments beyond monoclonal antibodies, and adoption of value-based pricing models.

The rising prevalence of autoimmune diseases is expected to propel the growth of the rheumatology therapeutics market going forward. An autoimmune disease is a condition where the immune system mistakenly attacks and damages the body's tissues. The prevalence of autoimmune diseases is growing due to a combination of genetic, environmental, and lifestyle factors, including increased awareness and improved diagnostic capabilities. Rheumatology therapeutics are required for autoimmune diseases to manage inflammation, alleviate symptoms, and prevent joint and tissue damage caused by the immune system attacking the body. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, around 514,000 people in Australia, or 2.0% of the population, were estimated to be living with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the burden for all musculoskeletal conditions in 2023. Therefore, the rising prevalence of autoimmune diseases is driving the growth of the rheumatology therapeutics market.

Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

The rheumatology therapeutics market covered in this report is segmented –

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes 2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy 3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Major companies operating in the rheumatology therapeutics market are developing innovative solutions, such as intravenous (IV) formulations, to enhance treatment efficacy and patient convenience. An intravenous (IV) formulation refers to a medication or substance that is administered directly into a vein through a needle or catheter. For instance, in October 2023, Novartis AG, a Switzerland-based pharmaceutical company, announced that the US Food and Drug Administration (FDA) had approved Cosentyx, an intravenous (IV) formulation. This form of Cosentyx is uniquely approved to treat adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). It works by specifically targeting and inhibiting interleukin-17A (IL-17A) and is the only non-tumor necrosis factor alpha (TNF-α) IV treatment available for these conditions.

The rheumatology therapeutics market report table of contents includes:

1. Executive Summary

2. Rheumatology Therapeutics Market Characteristics

3. Rheumatology Therapeutics Market Trends And Strategies

4. Rheumatology Therapeutics Market - Macro Economic Scenario

5. Global Rheumatology Therapeutics Market Size and Growth ...........

32. Global Rheumatology Therapeutics Market Competitive Benchmarking

33. Global Rheumatology Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Rheumatology Therapeutics Market

35. Rheumatology Therapeutics Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[trendingreportz]

Pharmacovigilance Market - Forecast(2024 - 2030)

 Pharmacovigilance Market Overview:

According to the U.S.-based Public Citizen’s Health Research Group, approximately two million people are affected by adverse drug reactions (ADR), which includes 100,000 fatalities, in the U.S. every year.[1] Traditionally, healthcare companies have utilized in-house and outsourcing pharmacovigilance services for effectively monitoring the positive effects as well as the side-effects of licensed medical drugs. Pharmacovigilance is a type of clinical research which determines drug safety and associated medical hazards, plans risk management, and anticipates remodification of drugs. It is aiding healthcare providers in easy detection and targeted spontaneous reporting of medication errors, thereby reducing risk of fatality. While the global pharmacovigilance market stood at $4.3 billion in 2018, the increasing scope of opportunities estimate the market to grow at a CAGR of 8.8% through to 2025.

ADR reporting is gaining increased end user appeal due to strict government policies for drug safety approval and testing. Approximately 61,311 people died due to drug poisoning in the United States as per the Insurance Information Institute.[2] North America, with a share of 37%, is the leading contributor to the pharmacovigilance market, followed by Europe and the Asia-Pacific region, in 2018. The outsourcing pharmacovigilance segment will generate sustainable demand, which is estimated to help the market grow at a CAGR of 8.8% during the forecast period 2019 to 2025.

Request Sample

Pharmacovigilance Market Growth Drivers:

· Stringent government regulations regarding drug administration, and increasing incidences of adversities resulting from from medication is boosting pharmacovigilance services, thereby providing greater possibilities for expanding the market size.

· Increasing medical errors, developing healthcare infrastructure and increasing pharmaceutical production are reducing fatal ADR incidents, and causing a positive impact on the pharmacovigilance market.

Inquiry Before Buying

Pharmacovigilance Market Key Players:

Leading companies in the pharmacovigilance market include Bristol- Myers Squibb, Boehringer Ingelheim, TCS, Cognizant, United BioSource, Covance, IQVIA (Quintiles IMS), Accenture,Paraxel, Wipro Limited, and others.

Bristol- Myers Squibb is a leading pharmaceutical manufacturing company which provides various products and solutions to end users, alongside conducting independent research on products and therapeutic methods.

Pharmacovigilance Market Trends:

· AI Enabled Pharmacovigilance:

Innovation in automation of mechanical procedures has led to advent of Artificial Intelligence (AI) methods, which are all set to take over the healthcare pharmacovigilance operative service. Genpact, a global digital transformation platform for industries, delivers Cora Pharmacovigilance facility for achieving quality insights and assessing, configuring, and signaling adverse events, thereby prioritizing patient safety. With its ability to provide end to end pharmacovigilance services, this technology can be incorporated with leading systems through AI and machine learning operations.

Schedule a Call

Pharmacovigilance Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Pharmacovigilance Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of pharmacovigilance services in Pharmacovigilance Market, and their specific applications in different areas.

Buy Now

Pharmacovigilance Market: Industry Coverage:

Global pharmacovigilance market is basically classified into clinical trial phases, and types of service providers. On the basis of clinical trial phases, categorization includes preclinical studies, phase I/1, phase II/2, phase III/3, and phase IV/4 trial. Based on the type of service providers bifurcation includes in-house, contract outsourcing, and others.

The Pharmacovigilance Market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia

[adityarana1687-blog]

Body, Mind And Energy Healing Market To Reach $394.73 Billion By 2030

The global body, mind and energy healing market size is anticipated to reach USD 394.73 billion by 2030, registering a CAGR of 26.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is witnessing significant growth, driven by mainstream acceptance of holistic health practices like acupuncture and yoga. This upsurge is linked to a more profound awareness of mental health issues and governmental integration of these practices into official healthcare policies. Millennials, leading the charge toward holistic health, amplify the demand for alternative complementary and alternative methods. Societal attitudes towards mental health are evolving, thanks to extensive awareness campaigns and research, making holistic treatments more appealing.

Adoption rates of alternative healing methods are notable; for instance, a survey shows that 35% of adults globally are turning to practices, such as meditation and herbal remedies for wellbeing. Regulatory bodies are also stepping up to ensure the safety and effectiveness of these approaches, while efforts to merge traditional methods with conventional healthcare are gaining momentum. The increasing pursuit of preventative and non-invasive treatments is shaping the market, with younger generations particularly favoring these natural healing options. In August 2023, the World Health Organization convened its first global summit on traditional medicine. The event aimed to integrate traditional and complementary medicine, like Ayurveda, yoga, and homeopathy, into mainstream healthcare. Over 100 countries adopted policies and strategies on traditional medicine following discussions on evidence-based approaches and international collaboration.

Request a free sample copy or view report summary: Body, Mind And Energy Healing Market Report

Body, Mind And Energy Healing Market Report Highlights

The mind healing segment held the largest revenue share in 2023 and is expected to grow at the highest CAGR over the forecast period due to growing awareness of mental health, alongside rising cases of conditions, such as anxiety and depression

The body healing segment is expected to grow at a significant CAGR over the forecast period owing to factors, such as consumer demand, technological advancements, and regulatory changes

The direct sales segment dominated the market in 2023 due to increasing consumer awareness and interest in holistic health practices, and growing acceptance of alternative therapies by mainstream society

The e-sales segment is expected to grow at the fastest CAGR from 2024 to 2030 owing to increased digitalization and online presence of practitioners, and the convenience of accessing services remotely

In October 2023, The Healing Company acquired Your Super and secured a USD 150M credit facility from i80 Group for brand expansion. The acquisition was financed with cash and equity, with Your Super's previous investors including PepsiCo and PowerPlant Partners

Body, Mind And Energy Healing Market Segmentation

Grand View Research has segmented the global body, mind and energy healing market based on intervention, distribution method, and region:

Body, Mind And Energy Healing Intervention Outlook (Revenue, USD Billion, 2018 - 2030)

Mind Healing

Autosuggestion

Hypnotherapy

Neuro-linguistic Programming

Self-hypnosis

Spiritual Mind Treatment

Transcendental Meditation

Body Healing

Acupressure

Acupuncture

Alexander Technique

Auriculotherapy

Autogenic Training

Chiropractic

Cupping Therapy

Kinesiology

Osteomyology

Osteopathy

Pilates

Qigong

Reflexology

Yoga

Energy Healing

Magnetic Therapy

Bio-magnetic Therapy

Magnetic Resonance Therapy

Radionics

Reiki

Therapeutic Touch

Chakra Healing

Sensory Healing

Body, Mind And Energy Healing Distribution Method Outlook (Revenue, USD Billion, 2018 - 2030)

Direct Sales

E-sales

Distance Correspondence

Body, Mind And Energy Healing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East & Africa (MEA)

South Africa

Saudi Arabia

Kuwait

UAE

List of Key Players of the Body, Mind And Energy Healing Market

The Healing Company Ltd.

Ramamani Iyengar Memorial Yoga Institute

John Schumacher Unity Woods Yoga Center

The Chopra Center; Canyon Ranch

Kripalu Center for Yoga & Health

Omega Institute

Esalen Institute

Spirit Rock Meditation Center

Shambhala Mountain Center

[healthcareanna]

Medical Sensors Market Growth Potential, Developments, Forecast

Medical Sensors Market Overview

The medical sensors market is an essential segment of the broader healthcare industry, pivotal in enabling precise diagnostics, monitoring, and therapeutic interventions. Medical sensors are devices used to detect, measure, and transmit biological signals, contributing significantly to patient care and treatment outcomes. Medical Sensors Market Size was valued at USD 8.53 Billion in 2023. The Global Medical Sensors industry is projected to grow from USD 8.99 Billion in 2024 to USD 15.90 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.45% during the forecast period (2024 - 2032).  This market has experienced significant growth due to technological advancements, increased prevalence of chronic diseases, and the rising demand for personalized medicine. As healthcare continues to evolve, the adoption of medical sensors is expected to become even more integral to modern medical practices.

Key Players

Medtronic plc

Abbott Laboratories

Philips Healthcare

Siemens Healthineers

GE Healthcare

Honeywell International Inc.

Texas Instruments Incorporated

Analog Devices, Inc.

STMicroelectronics

NXP Semiconductors N.V.

Drivers

Several factors are driving the expansion of the medical sensors market. Key among them is the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders. Medical sensors play a crucial role in monitoring these conditions in real-time, thus enabling timely interventions and improving patient outcomes. The growing emphasis on preventive healthcare and early diagnosis is also fueling the demand for advanced medical sensors.

Technological advancements are another significant driver. Innovations such as wearable sensors, Internet of Things (IoT) integration, and advancements in sensor accuracy and miniaturization have transformed the medical sensors landscape. These technologies facilitate continuous health monitoring, data collection, and remote patient management, leading to more personalized and efficient healthcare delivery.

Additionally, the increasing adoption of telemedicine and remote patient monitoring is propelling the medical sensors market. With the rise of telehealth services, there is a growing need for reliable and accurate sensors to collect and transmit patient data remotely. This trend is expected to continue as healthcare systems around the world embrace digital transformation.

Segmentation

The medical sensors market can be segmented based on type, application, and end-user.

By Type: This segmentation includes biosensors, temperature sensors, pressure sensors, image sensors, and others. Biosensors, which are used to detect biological changes in the body, are particularly significant due to their applications in glucose monitoring, cardiac monitoring, and other critical health assessments.

By Application: The applications of medical sensors span diagnostics, monitoring, and therapeutic interventions. Diagnostics sensors are used in laboratory settings to analyze patient samples, while monitoring sensors are crucial for continuous health tracking, such as heart rate and glucose levels. Therapeutic sensors are used to deliver treatments and monitor their efficacy.

By End-User: The end-users of medical sensors include hospitals, clinics, home care settings, and research institutions. Hospitals and clinics are the primary users due to their need for advanced diagnostic and monitoring equipment. Home care settings are increasingly adopting medical sensors as part of the trend towards remote patient monitoring.

Innovation and Product Development

Innovation is a driving force in the medical sensors market, with companies continuously developing new and improved products to meet the evolving needs of healthcare providers and patients. Advances in sensor technology have led to the creation of more accurate, reliable, and user-friendly devices. For instance, the development of wearable sensors has revolutionized the market, enabling continuous health monitoring and real-time data collection.

Recent innovations include the integration of artificial intelligence (AI) and machine learning algorithms with medical sensors. These technologies enhance data interpretation and predictive capabilities, allowing for more precise diagnostics and personalized treatment plans. Additionally, the development of non-invasive sensors has improved patient comfort and compliance, further driving market growth.

Product development in the medical sensors market also focuses on miniaturization and connectivity. Smaller, more compact sensors are becoming increasingly popular, as they can be embedded in wearable devices or even within the body. Connectivity features, such as wireless data transmission and IoT integration, are enhancing the functionality and usability of medical sensors, making them more accessible and efficient.

Regional Outlook

The medical sensors market exhibits diverse growth patterns across different regions.

North America holds a leading position in the global market, driven by advanced healthcare infrastructure, high adoption rates of new technologies, and substantial investments in research and development. The presence of major players and a robust regulatory framework further bolster the market in this region.

Europe is another significant market, with a focus on improving healthcare outcomes and integrating advanced technologies into healthcare systems. The growing prevalence of chronic diseases and the increasing adoption of telemedicine are contributing to market growth in Europe.

Asia-Pacific is experiencing rapid growth in the medical sensors market, driven by increasing healthcare investments, a rising population, and a growing focus on improving healthcare access and quality. Countries like China and India are witnessing significant advancements in medical sensor technology and adoption.

Latin America and Middle East & Africa are emerging markets with growing opportunities. Improvements in healthcare infrastructure and rising healthcare awareness are expected to drive market growth in these regions in the coming years.

In conclusion, the medical sensors market is poised for substantial growth driven by technological advancements, increasing healthcare demands, and innovations in product development. As the healthcare industry continues to evolve, medical sensors will play a pivotal role in enhancing patient care and health outcomes worldwide.

Related Reports-

Physical Therapy Equipment market

Genetic Testing market

Veterinary Medicine market

Virtual Clinical Trials market

2D Chromatography market

[tmr-blogs2]

Grid-scale Battery Market Size is Predicted to Attain US$ 55.3 Billion by 2031

The global electric tooth polishers market size stood at US$ 76.7 Mn in 2021 and is anticipated to expand at a CAGR of 5.5% from 2022 to 2031. Rise in demand for increasing the aesthetic appearance of teeth and rise in awareness about maintaining proper dental hygiene are expected to bolster market expansion during the forecast period. Surge in availability of effective over-the-counter teeth whitening products and advent of novel technologically advanced tooth polishing products are propelling market growth.

For More Details, Request for a Sample of this Research Report: https://www.transparencymarketresearch.com/electric-tooth-polisher-market.html

Electric Tooth Polisher Market: Key Findings of Report

Rise in Demand for Cosmetic Dentistry: Demand for cosmetic dentistry has increased in the past few years, as a large number of people are looking for ways to improve appearance of their teeth. This trend is bolstered by rise in importance that people place on their physical appearance, particularly in the digital age, where social media and online profiles play a significant role in how people present themselves to the world. Hence, the electric tooth polisher market has experienced significant growth, with more and more consumers seeking products that could help them achieve a brighter, more attractive smile.

Emergence of Technologically Advanced Products: Development of technologically advanced products has increased in the global market in the past few years. These products often feature cutting-edge technologies, such as ultrasonic cleaning, LED light therapy, and advanced brushing systems, which could help to effectively remove plaque and stains from teeth. Additionally, these products often come with a range of features and settings, allowing users to customize their tooth polishing experience to suit their specific needs and preferences.

Electric Tooth Polisher Market: Key Players

Leading companies operating in the global industry include Colgate, Koninklijke Philips N.V., Lobal Team Products (HK) Ltd., Quip, Foreo, KaVo Dental, Panasonic Corp., Henry Schein, Inc., Oral-B, Kerr Corporation, and Water Pik, Inc. These players are adopting various growth strategies in order to increase market share. These include M&As, launch of technologically advanced products, and expanding regional presence.

Electric Tooth Polisher Market: Regional Growth Assessment

North America accounted for the largest share of 36% of the global industry in 2021. Rise in disposable income, increase in awareness about dental hygiene, and surge in availability of next-gen dental cleaning products in the region are the key factors bolstering the market in North America.

Europe held the second largest share of 33% of the global industry in 2021. This is ascribed to rise in incidence of dental cavities, increase in number of dental clinics & hospitals in major countries, and presence of several established manufacturers in the region.

The market in Asia Pacific is expected to experience significant growth during the forecast period, expanding at a CAGR of 6.7% from 2022 to 2031. Leading factors driving the market are increase in awareness about dental hygiene, increase in adoption of innovative measures for elevating dental aesthetics, surge in disposable income, and rise in adoption of technologically advanced dental health devices.

Electric Tooth Polisher Market: Segmentation

Electric Tooth Polisher Market, by Type

Flat

Pointed

Electric Tooth Polisher Market, by Application

Therapeutic Polishing

Coronal / Cosmetic Polishing

Others (superficial and selective)

Electric Tooth Polisher Market, by End-user

Hospitals

Dental Clinics

Home Care

Others

Electric Tooth Polisher Market, by Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=85293&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

[neurofranchisecompany]

Effective Marketing Strategies for Promoting a Neuro PCD Company

A Neuro PCD Company is related to a very specialized and competitive sector of pharmaceuticals, focused on products for neurological and psychiatric disorders. These would be the focused strategic marketing approaches to promote the neuro segment of a company. The prevalence of neurological and psychiatric disorders is increasing day by day; hence, quality neuro medicines are in demand. In such a scenario, effective marketing strategies for Neuro Psychiatric PCD Pharma Companies become quite essential for the enhancement of their reach.

Marketing Strategies for Expanding a Neuro PCD Company

1. Understanding the Market Dynamics

Before marketing strategies are discussed, it is pertinent that a Neuropsychiatry PCD Pharma Franchise knows the market. The Neuro Segment contains gigantic therapeutic ranges for treating epilepsy, depression, schizophrenia, Alzheimer's, and Anxiety Disorder. Understanding the most prevalent neurological diseases in the geographical region the company is targeting will help mold the marketing efforts. Building partnership with Health care providers and Understanding the Needs of Health care Professionals is the Key for PCD Pharma Franchise in Neuro Segment.

2. Utilize Digital Marketing for Visibility

In this digital world, online marketing is of paramount help to create awareness about any pharma business. Having an attractive website, engaging social media, and search engine optimization can really contribute much to the visibility of your Neuropsychiatry Franchise Company.

Secondly, by using relevant keywords such as Neuro Psychiatric Pharma Franchise and incorporating SEO-optimized content, traffic can be drawn to the website. Informational blogs on neurodisorders, descriptions of products, and other learning resources can help brand the company as one of the most credible thought leaders in this sector. Paid ads are also possible, especially on social media, allowing targeting among certain health professionals, distributors, or other decision-makers.

3. Targeted Email Campaigns

Email marketing has been among the most potent tools for Psychiatry PCD Companies Franchise. Newsletters, product updates, and promotional offers can be mailed directly to current and potential clients, including professionals working in healthcare and distributors. By way of such segmented and personalized mails about the advantage of associating with your PCD Neuro Psychiatric Division, long-term associations can be built, provoking interest and response. A well-segmented email list helps companies target the right audience at the right time to acquire more conversions.

4. Offer Attractive Franchise Models

Provide an appealing model of a Neuro PCD Franchise, which comes under one of the important marketing strategies. The neuro segment has been rising rapidly, and a lot of pharmaceutical entrepreneurs are approaching for better opportunities. Provide information about the details pertaining to the benefits that would be derived by the associates or partners in choosing to franchise with your Neuro Medicine Company; basically, highlight monopoly rights, marketing support, and a wide range of quality products.

Via detailed brochures, franchise kits, and business proposal, one must be in a position to highlight the profitability of Neuropsychiatry Companies' for possible franchisees, as well as support them with close and transparent communication and basic training programs. This would help develop trust and loyalty between yourself and your partners.

5. Leverage Offline Marketing

Though digital marketing has a big role, one cannot resist offline marketing strategies in promoting Neuro Psychiatric PCD Pharma Companies. Participation in medical conferences and pharmaceutical exhibitions and health fairs provides an excellent platform to showcase your products and helps in developing relations with industry professionals. This can give you face-to-face interaction with healthcare providers, pharmacists, and neurologists to create a bigger brand presence in the neuro sector.

Distribute brochures, catalogs, business cards—printed material with detailed information about your Neuropsychiatry PCD Pharma Franchise. This will increase your credibility and scope.

6. Collaborate with Key Opinion Leaders (KOLs)

KOLs are of immense benefit to Neuropsychiatry Franchise Companies in the pharmaceutical industry. You can have these pros from neurology, psychiatry, or healthcare influencers work for your products and help lend credibility and visibility. Engaging KOLs in reviewing your products, participating in webinars, or even guest posting articles on your website will go a step further in enhancing the visibility and building trust in your company among health professionals.

7. Product Samples and Demonstrations

Offering product samples to healthcare professionals and distributors is an excellent way to highlight the efficacy and quality of your neuro medicines. Free samples of products to doctors and neurologists in geographical targets would let them experience the benefits and increase recommendations. Product demonstrations within hospitals or clinics will further enhance the offerings of your Neuro Psychiatric PCD Pharma Franchise.

8. Offer Continuous Customer Support

Effective marketing does not just stop here, like getting a new franchise partner or distributor on board. Other keys to retaining those clients include continuous support and long-term relationship building. After-sales support, frequent updating of the product, availing the marketing materials, and competitive pricing assure that your Neuropsychiatry PCD Pharma Franchise remains a long-term partner of choice.

Conclusion

Promotion of a Neuro PCD Company includes both digital and offline marketing strategies, specifically crafted according to the demand in the field of neuropsychiatry. An online presence, collaboration with KOLs, beautiful franchise models, and long-term relations with partners are ways by which Neuro Psychiatric PCD Pharma Companies can get extended reach with sustainable growth in this ultra-specialty pharmaceutical niche.

Company Contact Details

Company Name: Neuro Medicine Company  Mobile No: +91–7707977076 E-Mail: care@rednirus.in Website: www.neuromedicinecompany.com Address: SCO 207, Sector 14, Panchkula, 134109